← All trials
NCT04396873
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 27, 2020
- Primary completion
- Jan 16, 2023
- Completion date
- Jan 16, 2023
- First posted
- May 22, 2020
- Last posted
- May 22, 2020
- Enrollment
- 64
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Institute of Mental Health (NIMH)Lead sponsor
- National Institute of Mental Health (NIMH)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.